MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2026-27)
- Udyam number
- UDYAM-GJ-01-0035696
Market Cap
₹180 Cr
NEOCHEM-SM · NSE
Share Price
₹106.10
+1.05% today
Revenue
₹84.17 Cr
FY 2024-25 · +37.7% YoY
EBITDA
₹13.12 Cr
Margin 15.6%
Net Profit
₹7.69 Cr
FY 2024-25 · +327.2% YoY
P/E (TTM)
23.3x
P/B 2.5x
ROE
48.8%
ROCE 27.2%
Debt / Equity
2.17
Interest cover 29.8x
About Neochem Bio Solutions Limited
Data last updated:
Neochem Bio Solutions Limited is a public limited company based in Ahmedabad, Gujarat, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 06 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L24304GJ2017PLC097754. Its GSTIN is 24AAFCN6825L1Z6 (Gujarat). The company holds 2 GST registrations, all of them active. It is a listed company as per MCA records. Its shares are listed on NSE: NEOCHEM.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹17.12 Cr. It is led by directors including Swapnil Rameshbhai Makati (Managing Director) and Hemangini Swapnil Dathia (Whole-Time Director).
Its last annual general meeting (AGM) was held on 04 July 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 303 W1 Opp. Vikramnagar Colony, Off. Iscok – Ambli Road Ahmedabad, Gujarat, India – 380058.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹110.7 Cr, a growth of 31.5% compared to the previous year. For the same year it recorded a net profit of ₹12.5 Cr (net margin 11.3%) and EBITDA of ₹19.24 Cr (EBITDA margin 17.4%). The net worth stands at ₹78.84 Cr (up 299% YoY). Total assets are valued at ₹97.77 Cr (up 75.6% YoY).
The company has about 76 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹40.07 Cr and satisfied charges of ₹72.36 Cr on record.
Neochem Bio Solutions Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0035696). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website neochem.in.
Company details
CIN L24304GJ2017PLC097754
Registration Number 097754
Incorporation Date 06 June 2017
ROC Ahmedabad
Listing Status Listed (NSE: NEOCHEM)
Company Status Active
Date of Last AGM 04 July 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-01-0035696
CIN history
Neochem Bio Solutions has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24304GJ2017PLC097754, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24304GJ2017PLC097754 | Current |
| U24304GJ2017PTC097754 | Previous |
| U24304GJ2017PLC097754 | Previous |
Key People
Swapnil Rameshbhai Makati Managing Director Hemangini Swapnil Dathia Whole-Time Director Dinesh Chopra Director Recognitions & Rankings of Neochem Bio Solutions
Contact details
Neochem Bio Solutions Limited's registered office is in Daskroi, Gujarat.
- Registered Address303 W1 Opp. Vikramnagar Colony, Off. Iscok – Ambli Road Ahmedabad, Gujarat, India – 380058
- IndustryChemicals and Materials, Specialty Chemicals
Comprehensive company report
Neochem Bio Solutions Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Neochem Bio Solutions is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Neochem Bio Solutions Limited, buy the company report.
Financials of Neochem Bio Solutions Limited
FY 2025-26 filings availableNeochem Bio Solutions Limited reported revenue of ₹110.7 Cr (up 31.5% YoY) for FY 2025-26.
Financial Highlights
FY 2024-25 · ConsolidatedRevenue
₹84.17 Cr
+37.6% YoY
EBITDA
₹13.12 Cr
+118.7% YoY
Profit After Tax
₹7.69 Cr
+327.2% YoY
Net Worth
₹19.76 Cr
+64.5% YoY
Total Assets
₹55.69 Cr
+22.2% YoY
Total Debt
₹35.63 Cr
+6.9% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Income statement | |||
| Revenue | 84.17 | 61.15 | 48.19 |
| Revenue growth | +37.7% | +26.9% | - |
| EBITDA | 13.12 | 6.00 | 4.24 |
| EBITDA margin | +15.6% | +9.8% | +8.8% |
| Profit before tax | 10.26 | 2.68 | 1.52 |
| Net profit | 7.69 | 1.80 | 1.08 |
| Net profit margin | +9.1% | +2.9% | +2.2% |
| EPS (₹) | 11.61 | 2.70 | 1.98 |
| Balance sheet | |||
| Total assets | 55.69 | 45.59 | 34.47 |
| Net worth | 19.76 | 12.01 | 8.06 |
| Total debt | 35.63 | 33.32 | 26.24 |
| Cash & bank | 0.06 | 0.35 | 0.05 |
| Net working capital | 30.49 | 20.96 | 16.60 |
| Cash flow | |||
| Cash from operations | 2.59 | 1.96 | (0.74) |
| Cash from investing | (1.69) | (7.86) | (3.35) |
| Cash from financing | (1.20) | 6.20 | 3.76 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 111 | 84.17 | 61.15 | 48.19 | 48.60 |
| Revenue growth | +31.5% | +37.7% | +26.9% | -0.8% | - |
| EBITDA | 19.24 | 12.80 | 6.13 | 4.30 | 3.52 |
| EBITDA margin | +17.4% | +15.2% | +10.0% | +8.9% | +7.2% |
| Profit before tax | 17.19 | 9.94 | 2.81 | 1.58 | 1.29 |
| Net profit | 12.50 | 7.34 | 1.94 | 1.14 | 0.97 |
| Net profit margin | +11.3% | +8.7% | +3.2% | +2.4% | +2.0% |
| EPS (₹) | 7.02 | 11.15 | 2.89 | 2.10 | 3.24 |
| Balance sheet | |||||
| Total assets | 97.77 | 55.69 | 45.64 | 34.55 | 27.36 |
| Net worth | 78.84 | 19.76 | 12.32 | 8.39 | 4.09 |
| Total debt | 17.79 | 35.63 | 33.33 | 26.17 | 23.27 |
| Cash & bank | 0.18 | 0.06 | 0.35 | 0.05 | 0.39 |
| Net working capital | 67.12 | 30.49 | 20.57 | 16.34 | 10.82 |
| Cash flow | |||||
| Cash from operations | (16.94) | 2.04 | (0.64) | (0.97) | (1.46) |
| Cash from investing | (8.67) | (1.13) | 11.52 | (3.32) | (2.74) |
| Cash from financing | 25.73 | (1.20) | (10.57) | 3.95 | 4.33 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 05 Nov 2026
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue | 84.17 | 61.15 | 48.19 |
| Revenue growth | +37.7% | +26.9% | - |
| Other income | 1.98 | 0.86 | 0.60 |
| Total expenses | 71.05 | 55.15 | 43.95 |
| Employee cost | 6.75 | 7.23 | 5.86 |
| EBITDA | 13.12 | 6.00 | 4.24 |
| EBITDA margin | +15.6% | +9.8% | +8.8% |
| Depreciation | 1.33 | 1.22 | 1.22 |
| Interest | 3.51 | 2.96 | 2.10 |
| Profit before tax | 10.26 | 2.68 | 1.52 |
| Tax | 2.51 | 0.87 | 0.44 |
| Net profit | 7.69 | 1.80 | 1.08 |
| Net profit margin | +9.1% | +2.9% | +2.2% |
| EPS (₹) | 11.61 | 2.70 | 1.98 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Equity & liabilities | |||
| Share capital | 6.68 | 6.68 | 5.43 |
| Reserves & surplus | 13.08 | 5.33 | 2.63 |
| Shareholders' funds (net worth) | 19.76 | 12.01 | 8.06 |
| Minority interest | 0.00 | 0.00 | 0.00 |
| Secured loans | 32.34 | 27.32 | 22.01 |
| Unsecured loans | 3.29 | 6.00 | 4.23 |
| Total debt | 35.63 | 33.32 | 26.24 |
| Total liabilities | 55.69 | 45.59 | 34.47 |
| Assets | |||
| Gross block | 24.31 | 23.61 | 18.46 |
| Net block | 18.67 | 18.81 | 14.67 |
| Capital work in progress | 0.06 | 0.03 | 0.04 |
| Investments | 0.00 | 0.00 | 0.00 |
| Inventories | 23.76 | 18.21 | 14.93 |
| Sundry debtors | 25.28 | 17.24 | 14.42 |
| Cash & bank balances | 0.06 | 0.35 | 0.05 |
| Loans & advances | 3.99 | 2.89 | 2.59 |
| Total current assets | 53.09 | 38.69 | 31.99 |
| Total current liabilities | 22.60 | 17.73 | 15.39 |
| Net working capital | 30.49 | 20.96 | 16.60 |
| Total assets | 55.69 | 45.59 | 34.47 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Opening cash | 0.35 | 0.05 | 0.38 |
| Net cash from operating activities | 2.59 | 1.96 | (0.74) |
| Net cash from investing activities | (1.69) | (7.86) | (3.35) |
| Net cash from financing activities | (1.20) | 6.20 | 3.76 |
| Net change in cash | (0.30) | 0.30 | (0.34) |
| Closing cash | 0.06 | 0.35 | 0.05 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Growth | |||
| Sales growth | +37.7% | +26.9% | - |
| EBITDA growth | +118.7% | +41.5% | - |
| PBT growth | +282.8% | +76.3% | +9997.0% |
| Net income growth | +327.2% | +66.7% | - |
| Profitability & leverage | |||
| Net income margin | +9.2% | +3.0% | +2.2% |
| Return on capital employed | +27.2% | +14.1% | +10.5% |
| Return on net worth | +48.8% | +17.9% | +13.3% |
| Debt / equity | 2.17 | 2.97 | 3.26 |
| Long-term debt / equity | 1.02 | 1.52 | 1.54 |
| Interest cover | 29.77 | 61.92 | 69.54 |
| Efficiency & per share | |||
| Fixed asset turnover | 3.51 | 2.91 | 2.61 |
| Inventory turnover | 4.01 | 3.69 | 3.23 |
| Debtors turnover | 3.96 | 3.86 | 3.34 |
| EPS (₹) | 11.61 | 2.70 | 1.98 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 29.59 | 17.98 | 14.84 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Revenue | 111 | 84.17 | 61.15 | 48.19 | 48.60 |
| Revenue growth | +31.5% | +37.7% | +26.9% | -0.8% | - |
| Other income | 2.70 | 1.98 | 0.86 | 0.60 | 0.09 |
| Total expenses | 91.46 | 71.37 | 55.02 | 43.89 | 45.08 |
| Employee cost | 6.88 | 7.06 | 7.10 | 5.79 | 4.48 |
| EBITDA | 19.24 | 12.80 | 6.13 | 4.30 | 3.52 |
| EBITDA margin | +17.4% | +15.2% | +10.0% | +8.9% | +7.2% |
| Depreciation | 1.24 | 1.33 | 1.22 | 1.22 | 1.04 |
| Interest | 3.51 | 3.51 | 2.96 | 2.10 | 1.28 |
| Profit before tax | 17.19 | 9.94 | 2.81 | 1.58 | 1.29 |
| Tax | 5.16 | 2.51 | 0.87 | 0.44 | 0.32 |
| Net profit | 12.50 | 7.34 | 1.94 | 1.14 | 0.97 |
| Net profit margin | +11.3% | +8.7% | +3.2% | +2.4% | +2.0% |
| EPS (₹) | 7.02 | 11.15 | 2.89 | 2.10 | 3.24 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Equity & liabilities | |||||
| Share capital | 17.12 | 6.68 | 6.68 | 5.43 | 3.00 |
| Reserves & surplus | 61.72 | 13.08 | 5.64 | 2.96 | 1.09 |
| Shareholders' funds (net worth) | 78.84 | 19.76 | 12.32 | 8.39 | 4.09 |
| Secured loans | 17.44 | 30.88 | 26.01 | 19.53 | 16.50 |
| Unsecured loans | 0.35 | 4.75 | 7.32 | 6.64 | 6.77 |
| Total debt | 17.79 | 35.63 | 33.33 | 26.17 | 23.27 |
| Total liabilities | 97.77 | 55.69 | 45.64 | 34.55 | 27.36 |
| Assets | |||||
| Gross block | 26.50 | 24.31 | 23.60 | 18.46 | 15.01 |
| Net block | 19.92 | 18.67 | 18.80 | 14.67 | 12.44 |
| Capital work in progress | 0.06 | 0.06 | 0.03 | 0.04 | 0.15 |
| Investments | 6.25 | 0.00 | 0.00 | 0.09 | 0.09 |
| Inventories | 29.25 | 23.76 | 18.21 | 14.93 | 13.29 |
| Sundry debtors | 48.72 | 25.28 | 16.80 | 14.16 | 13.63 |
| Cash & bank balances | 0.18 | 0.06 | 0.35 | 0.05 | 0.39 |
| Loans & advances | 7.76 | 3.99 | 2.29 | 2.58 | 1.81 |
| Total current assets | 85.91 | 53.09 | 37.65 | 31.72 | 29.12 |
| Total current liabilities | 18.79 | 22.60 | 17.08 | 15.38 | 18.30 |
| Net working capital | 67.12 | 30.49 | 20.57 | 16.34 | 10.82 |
| Total assets | 97.77 | 55.69 | 45.64 | 34.55 | 27.36 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Opening cash | 0.06 | 0.35 | 0.05 | 0.39 | 0.27 |
| Net cash from operating activities | (16.94) | 2.04 | (0.64) | (0.97) | (1.46) |
| Net cash from investing activities | (8.67) | (1.13) | 11.52 | (3.32) | (2.74) |
| Net cash from financing activities | 25.73 | (1.20) | (10.57) | 3.95 | 4.33 |
| Net change in cash | 0.13 | (0.30) | 0.30 | (0.34) | 0.12 |
| Closing cash | 0.18 | 0.06 | 0.35 | 0.05 | 0.39 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Growth | |||||
| Sales growth | +31.5% | +37.7% | +26.9% | -0.8% | - |
| EBITDA growth | +50.3% | +108.8% | +42.6% | +22.2% | - |
| PBT growth | +72.9% | +253.7% | +77.9% | +22.5% | +9997.0% |
| Net income growth | +70.3% | +278.4% | +70.2% | +17.5% | - |
| Revenue CAGR (3Y) | +32.0% | +20.1% | - | - | - |
| EBITDA CAGR (3Y) | +64.8% | +53.8% | - | - | - |
| Profitability & leverage | |||||
| Net income margin | +10.9% | +8.8% | +3.2% | +2.4% | +2.0% |
| Return on capital employed | +27.0% | +26.6% | +14.4% | +11.9% | +9.4% |
| Return on net worth | +24.4% | +46.4% | +18.6% | +18.3% | +23.7% |
| Debt / equity | 0.54 | 2.15 | 2.87 | 3.96 | 5.69 |
| Long-term debt / equity | 0.15 | 1.01 | 1.47 | 2.20 | 3.69 |
| Interest cover | 19.50 | 30.60 | 60.29 | 68.18 | 51.61 |
| Efficiency & per share | |||||
| Fixed asset turnover | 4.36 | 3.51 | 2.91 | 2.88 | 3.24 |
| Inventory turnover | 4.18 | 4.01 | 3.69 | 3.42 | 3.66 |
| Debtors turnover | 2.99 | 4.00 | 3.95 | 3.47 | 3.57 |
| EPS (₹) | 7.02 | 11.15 | 2.89 | 2.10 | 3.24 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 46.05 | 29.59 | 18.45 | 15.46 | 13.64 |
To see the full year-wise statements and ratios of Neochem Bio Solutions Limited, buy the company report.
Board of directors of Neochem Bio Solutions Limited
Neochem Bio Solutions has 6 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swapnil Rameshbhai Makati | Managing Director | 06 Jun 2017 | 9 Years 4 Months | Current |
| Hemangini Swapnil Dathia | Whole-Time Director | 25 Sep 2020 | 6 Years 1 Months | Current |
| Dinesh Chopra | Director | 11 Jul 2021 | 5 Years 3 Months | Current |
| Falgunbhai Prajapati | Director | 16 Jun 2025 | 1 Years 4 Months | Current |
| Rajasekaran Guha | Director | 16 Jun 2025 | 1 Years 4 Months | Current |
| Shail Jayesh Shah Also directs: GSP Crop Science Limited, HRS Aluglaze Limited, Rajdhani Petrochemicals Private Limited and 1 more | Director | 16 Jun 2025 | 1 Years 4 Months | Current |
Peer comparison
Neochem Bio Solutions Limited is compared with the 5 companies closest to it by revenue in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neochem Bio Solutions Limitedthis company | ₹110.7 Cr (FY 2026) | ₹12.5 Cr | 11.3% | 31.5% | Ahmedabad, Gujarat, India | |
| Shhivtek Plasticiser Private Limited | ₹87.8 Cr (FY 2025) | 50.0% | Delhi, India | |||
| TP Buildtech Private Limited | ₹87.34 Cr (FY 2025) | 36.0% | New Delhi, Delhi, India | |||
| Advent Chembio Private Limited | ₹85.63 Cr (FY 2024) | -8.0% | Navi Mumbai, Maharashtra, India | |||
| Gujarat Boron Derivatives Pvt Ltd | ₹85.53 Cr (FY 2025) | 43.0% | Vadodara, Gujarat, India | |||
| Expede-Tech Research & Development Private Limited | ₹85.41 Cr (FY 2025) | 128.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Neochem Bio Solutions Limited, buy the company report.
Charges & borrowings
Open charges
₹40.07 Cr
Satisfied charges
₹72.36 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Jul 2026 | 101359293 | Others | ₹82.05 Lakh | Open | |
| 27 Jul 2026 | 101352558 | Axis Bank Limited | ₹4.25 Cr | Open | |
| 01 Oct 2025 | 101173566 | State Bank of India | ₹5 Cr | Open | |
| 26 Jun 2025 | 101130179 | Others | ₹5 Cr | Open | |
| 06 Sep 2023 | 100788496 | Axis Bank Limited | ₹25 Cr | Open |
To see the full charge records of Neochem Bio Solutions Limited, buy the company report.
Total charge records: 13 View all charges
Legal cases
No court or tribunal cases involving Neochem Bio Solutions Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Neochem Bio Solutions Limited has 8 MSME Form 1 returns on record between 2019 and 2023, listing 948 overdue payments to 104 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 104)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Vital Chemtech Limited | |||
| Remik Trading Corporation | |||
| an individual supplier | |||
| Zyvana Integrated Services Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Neochem Bio Solutions Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Neochem Bio Solutions has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAFCN6825L1Z6 | Gujarat | Active | 01 Jul 2017 |
| 24AAFCN6825L2Z5 | Gujarat | Active | 21 Nov 2021 |
To see the full GST registrations and return filing status of Neochem Bio Solutions Limited, buy the company report.
Recent activity
Neochem Bio Solutions Limited has 11 board changes on record since 2017: 7 appointments and 4 cessations. The latest: Falgunbhai Prajapati was appointed as Director on 16 Jun 2025.
Charges
A charge with Others amounted to Rs. 0.82 Cr with Charge ID 101359293 was registered on 29 Jul 2026.
Charges
A charge with Axis Bank Limited amounted to Rs. 4.25 Cr with Charge ID 101352558 was registered on 27 Jul 2026.
Filing
Neochem Bio Solutions Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Ahmedabad.
Charges
A charge registered on 12 Sep 2023 via Charge ID 100790119 with Others was fully satisfied on 03 Jan 2026.
Charges
A charge with Axis Bank Limited of Rs. 25.00 Cr registered on 06 Sep 2023 with Charge ID 100788496 was modified on 06 Oct 2025.
Charges
A charge with State Bank Of India amounted to Rs. 5.00 Cr with Charge ID 101173566 was registered on 01 Oct 2025.
AGM
Neochem Bio Solutions Limited last Annual general meeting of members was held on 04 Jul 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 101130179 was registered on 26 Jun 2025.
Appointed
Falgunbhai Prajapati was appointed as Director.
Appointed
Pradip Ramniklal Solanki was appointed as CFO.
Appointed
Rajasekaran Guha was appointed as Director.
Appointed
Shail Jayesh Shah was appointed as Director.
30 earlier events are in the company report.
Frequently asked questions
Neochem Bio Solutions is an active public limited company based in Ahmedabad, Gujarat, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 06 June 2017 (9+ years old) and is registered under CIN L24304GJ2017PLC097754. Listed on NSE: NEOCHEM.
Neochem Bio Solutions reported revenue of ₹110.7 Cr for FY 2025-26 (up 31.5% YoY) based on standalone financials.
Neochem Bio Solutions has 6 current directors:
- Swapnil Rameshbhai Makati - Managing Director
- Hemangini Swapnil Dathia - Whole-Time Director
- Dinesh Chopra - Director
- Falgunbhai Prajapati - Director
- Rajasekaran Guha - Director
- Shail Jayesh Shah - Director
The latest financial statements of Neochem Bio Solutions on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 04 July 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Neochem Bio Solutions is 24AAFCN6825L1Z6, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAFCN6825L2Z5 (Gujarat).
The CIN (Corporate Identification Number) of Neochem Bio Solutions is L24304GJ2017PLC097754. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Neochem Bio Solutions is a listed company as per MCA records. Its shares are listed on NSE (symbol: NEOCHEM).
Neochem Bio Solutions was incorporated on 06 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Neochem Bio Solutions by revenue are Shhivtek Plasticiser Private Limited, TP Buildtech Private Limited, Advent Chembio Private Limited, Gujarat Boron Derivatives Pvt Ltd, Expede-Tech Research & Development Private Limited, all in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Falgunbhai Prajapati was appointed as Director on 16 Jun 2025. Pradip Ramniklal Solanki was appointed as CFO on 16 Jun 2025. Rajasekaran Guha was appointed as Director on 16 Jun 2025. Neochem Bio Solutions has 11 board changes on record in total.
Yes, Neochem Bio Solutions is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-01-0035696).
Neochem Bio Solutions has 8 MSME Form 1 returns on record between 2019 and 2023, listing 948 overdue payments to 104 micro and small suppliers. The latest return was filed on 29 Aug 2023.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages